✦ LIBER ✦

9150 Phase I trial of vorinostat in combination with erlotinib for advanced non-small cell lung cancer (NSCLC) patients (pts) with EGFR mutations after erlotinib progression (NCT00503971): The TARZO trial

✍ Scribed by Reguart, N.; Isla, D.; Cardona, A.F.; Palmero, R.; Cardenal, F.; Rolfo, C.; Montañes, A.; Queralt, C.; Carcereny, E.; Rosell, R.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

9141 POSTER Phase l/ll Trial of Vorinost

✍ Cardenal, F.; Reguart, N.; Morán, T.; Insa, A.; Isla, L.; Magern, M.; Rolfo, C.; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Phase I/II trial of vorinostat (SAHA) an

✍ Reguart, Noemi; Rosell, Rafael; Cardenal, Felipe; Cardona, Andres F.; Isla, Dolo 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 645 KB

A phase I trial of the combination taxot

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 173 KB

9016 POSTER DISCUSSION Erlotinib Vs Chem

✍ De Marinis, F.; Rosell, R.; Vergnenegre, A.; Massuti, B.; Felip, E.; Gervais, R. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB

9148 Phase 1 study of the toll-like rece

✍ Smith, D.A.; Conkling, P.; Richards, D.; Alemany, C.; Boyd, T.; Garbo, L.; Wu, H 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 68 KB

O-245 Randomized phase II clinical trial

✍ Rosell, Rafael; Constenla, Manuel; Kolb, Rainer; Pfeiffer, Wolfang; O'Bryne, Ken 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 178 KB